TAG:
comparative clinical pathology
June 12, 2006 “Intelligence: Late Breaking Lab News”
Many changes are unfolding across the laboratory industry, so we begin with some of the more significant developments involving people: TRANSITIONS •One of clinical pathology’s respected veterans is preparing to retire. Elkin Simson, M.D., Medical Director at th…
CURRENT ISSUE
Volume XXVII, No. 12 – August 24, 2020
THE DARK REPORT lines up its top lab industry experts to analyze a surprising development: The department of Health and Human Services’ welcome announcement that the Food and Drug Administration does not need to issue an Emergency Use Authorization for laboratory-developed tests. This announcement is significant because EUAs for LDTs have been a long-running irritant to labs. But lab managers will want to consider whether liability issues make a voluntary EUA advisable, based on TDR’s analysis.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
